Viewpoint
|
Open Access
Featured
-
-
Article
| Open AccessSwitch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data
- Eleonora Riccio
- , Mario Zanfardino
- & Annamaria Colao
-
Comment |
The GDPR, secondary research purposes and global data sharing—one-wheel too many
- Sirpa Soini
-
Brief Communication
| Open AccessGene therapy regulation: could in-body editing fall through the net?
- Miranda Mourby
- & Michael Morrison
-
Review Article
| Open AccessDisruptive and avoidable: GDPR challenges to secondary research uses of data
- David Peloquin
- , Michael DiMaio
- & Mark Barnes
-
Brief Communication |
Moving towards a cure in genetics: what is needed to bring somatic gene therapy to the clinic?
- Martina C. Cornel
- , Heidi C. Howard
- & Kirmo Wartiovaara